Rhonda L Bitting, MD

Associate Professor of Medicine
member of the duke Cancer Institute
Campus mail 905 S Lasalle St, Rm 2052, Durham, NC 27710
Phone (919) 613-1887
Email address rhonda.bitting@duke.edu

Education and Training

  • Fellowship, Hematology And Oncology, Duke University, 2009 - 2012
  • Residency, Internal Medicine, University of California, School of Medicine, 2006 - 2008
  • M.D., Vanderbilt University, 2005

Publications

Hanson, Erik D., Mohamdod Alzer, Jackson Carver, Cameron K. Stopforth, Alexander R. Lucas, Young E. Whang, Matthew I. Milowsky, et al. “Feasibility of home-based exercise training in men with metastatic castration-resistant prostate cancer.” Prostate Cancer Prostatic Dis, March 19, 2022. https://doi.org/10.1038/s41391-022-00523-8.

PMID
35306542
Full Text

Bitting, Rhonda L., Patrick Healy, Daniel J. George, Monika Anand, Sung Kim, Tina Mayer, Carol Winters, et al. “Phase II Trial of Enzalutamide and Androgen Deprivation Therapy with Salvage Radiation in Men with High-risk Prostate-specific Antigen Recurrent Prostate Cancer: The STREAM Trial.” Eur Urol Oncol 4, no. 6 (December 2021): 948–54. https://doi.org/10.1016/j.euo.2020.01.005.

PMID
32063492
Full Text

Hanson, Erik D., Cameron K. Stopforth, Mohamdod Alzer, Jackson Carver, Alexander R. Lucas, Young E. Whang, Matthew I. Milowsky, et al. “Body composition, physical function and quality of life in healthy men and across different stages of prostate cancer.” Prostate Cancer Prostatic Dis 24, no. 3 (September 2021): 725–32. https://doi.org/10.1038/s41391-020-00317-w.

PMID
33495569
Full Text

Freedland, S. J., R. Sandin, S. T. Tagawa, Z. Klaassen, R. L. Bitting, K. Ramaswamy, B. Emir, et al. “609P Treatment patterns and overall survival (OS) in metastatic castration-sensitive prostate cancer (mCSPC) from 2006 to 2019.” In Annals of Oncology, 32:S650–51. Elsevier BV, 2021. https://doi.org/10.1016/j.annonc.2021.08.1122.

Full Text

George, Daniel J., Susan Halabi, Elisabeth I. Heath, A Oliver Sartor, Guru P. Sonpavde, Devika Das, Rhonda L. Bitting, et al. “A prospective trial of abiraterone acetate plus prednisone in Black and White men with metastatic castrate-resistant prostate cancer.” Cancer 127, no. 16 (August 15, 2021): 2954–65. https://doi.org/10.1002/cncr.33589.

PMID
33951180
Full Text

Pachynski, Russell K., Chihiro Morishima, Russell Szmulewitz, Lauren Harshman, Leonard Appleman, Paul Monk, Rhonda L. Bitting, et al. “IL-7 expands lymphocyte populations and enhances immune responses to sipuleucel-T in patients with metastatic castration-resistant prostate cancer (mCRPC).” Journal for Immunotherapy of Cancer 9, no. 8 (August 2021). https://doi.org/10.1136/jitc-2021-002903.

PMID
34452927
Full Text

Bitting, Rhonda L., Janet A. Tooze, Scott Isom, W Jeffrey Petty, Stefan C. Grant, Rodwige J. Desnoyers, Alexandra Thomas, et al. “Phase I Study of Muscadine Grape Extract for Patients With Advanced Cancer.” Am J Clin Oncol 44, no. 6 (June 1, 2021): 239–46. https://doi.org/10.1097/COC.0000000000000814.

PMID
33867481
Full Text

Labriola, Matthew K., Saad Atiq, Nathan Hirshman, and Rhonda L. Bitting. “Management of men with metastatic castration-resistant prostate cancer following potent androgen receptor inhibition: a review of novel investigational therapies.” Prostate Cancer Prostatic Dis 24, no. 2 (June 2021): 301–9. https://doi.org/10.1038/s41391-020-00299-9.

PMID
33168966
Full Text

Zhang, Tian, Bridget F. Koontz, Scott T. Tagawa, Himanshu Nagar, Rhonda L. Bitting, Bart Frizzell, Luke T. Nordquist, et al. “Interim analysis of STARTAR: A phase II salvage trial of androgen receptor (AR) inhibition with androgen deprivation therapy (ADT) and apalutamide with radiation therapy (RT) followed by docetaxel in men with PSA recurrent prostate cancer (PC) after radical prostatectomy (RP).” In Journal of Clinical Oncology, 39:90–90. American Society of Clinical Oncology (ASCO), 2021. https://doi.org/10.1200/jco.2021.39.6_suppl.90.

Full Text

Bitting, Rhonda L., Donald Charles Vile, Janet A. Tooze, Christopher Y. Thomas, Morgan Neve, Mitra Kooshki, Jessica Brown, Purnima Dubey, Pierre Triozzi, and Michael Moses Goodman. “Single-arm phase II study of low-dose paclitaxel and pembrolizumab in platinum-refractory metastatic urothelial carcinoma (UC).” In Journal of Clinical Oncology, 39:433–433. American Society of Clinical Oncology (ASCO), 2021. https://doi.org/10.1200/jco.2021.39.6_suppl.433.

Full Text

Pages